Jeffrey K Kondo

Title: The Innovations of Jeffrey K Kondo

Introduction

Jeffrey K Kondo is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of biotechnology, particularly in the area of phage resistance in bacteria. With a total of 5 patents, Kondo's work has implications for industrial fermentation processes.

Latest Patents

Kondo's latest patents include the development of a DNA encoding phage resistance protein, known as Abi900. This novel protein, consisting of 183 amino acids, was isolated from a natural plasmid (pSRQ900) of Lactococcus lactis. When introduced into dairy starter cultures, the Abi900 protein provides strong resistance to bacteriophage infection. Another significant patent involves the DNA encoding a phage abortive infection protein from Lactococcus lactis, designated as AbiE. This DNA, contained in a Lactococcus lactis strain deposited as NRRL-B-21443, is incorporated into bacteria to encode the AbiE and enhance phage resistance. These innovations are particularly useful in industrial fermentations where phage contamination poses a challenge.

Career Highlights

Throughout his career, Kondo has worked with various companies, including Quest International B.V. and Quest International Flavors & Food Ingredients Co. His expertise in biotechnology has allowed him to contribute to advancements in food science and fermentation technology.

Collaborations

Kondo has collaborated with notable colleagues such as Ebenezer R Vedamuthu and Barbara J Holler. These partnerships have furthered his research and development efforts in the field.

Conclusion

Jeffrey K Kondo's innovative work in phage resistance proteins has the potential to revolutionize industrial fermentation processes. His contributions to biotechnology are significant and continue to impact the industry positively.